Activin receptor-like kinase 1 (ALK-1) is a type I cell surface receptor for members of the transforming growth factor-beta (TGF-β) superfamily. This family comprises a wide array of growth and differentiation factors that play essential roles in embryonic development, tissue homeostasis, and a multitude of physiological processes. ALK-1 is predominantly expressed in endothelial cells, where it modulates angiogenesis, the process by which new blood vessels form from pre-existing ones. When ligands such as bone morphogenetic proteins (BMPs) bind to ALK-1, it forms a complex with type II receptors, leading to the phosphorylation of intracellular signaling proteins. These activated proteins, in turn, propagate the signal into the cell, influencing gene transcription and cellular responses. ALK-1's intricate involvement in vascular development and homeostasis underscores its significance in maintaining the fine balance between vascular growth and stability.
Activators of ALK-1 are molecules or compounds that promote the expression, dimerization, or signaling activity of ALK-1. These activators may function by enhancing the transcription or translation of the ALK-1 gene, stabilizing the receptor's structure on the cell surface, or potentiating its interaction with ligands or co-receptors. The presence of ALK-1 activators can have profound implications on endothelial cell behavior, influencing processes like cell migration, proliferation, and tube formation. Venturing into the domain of ALK-1 activators offers a deep understanding of the complexities of TGF-β receptor signaling. As the expansive tapestry of cell signaling continues to be elucidated, the role of ALK-1 and its activators stands as a captivating chapter, revealing the molecular intricacies that shape vascular biology and endothelial function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Can modulate TGF-β signaling, potentially influencing ALK-1 activation indirectly. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Although primarily an inhibitor of ALK4, ALK5, and ALK7, it might have off-target effects or indirect effects on ALK-1 activation. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Primarily an inhibitor of ALK2 and ALK3 but might influence ALK-1 activation in specific contexts or indirectly. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Known to inhibit BMP signaling through ALK2, ALK3, and ALK6 and might have off-target or indirect effects on ALK-1. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $88.00 | 3 | |
An inhibitor of the TGF-β receptor I kinases ALK4, ALK5, and ALK7. Potential off-target or indirect effects on ALK-1. | ||||||